Rewiring innate and adaptive immunity with TLR9 agonist to treat osteosarcoma

Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer

Suzanne L. Topalian, F. Stephen Hodi, Julie R. Brahmer et al. · New England Journal of Medicine · 2012 · 12.5K citations · Full text

Redirecting <i>In vivo</i> Elicited Tumor Infiltrating Macrophages and Dendritic Cells towards Tumor Rejection

Cristiana Guiducci, Alain Vicari, Sabina Sangaletti et al. · Cancer Research · 2005 · 547 citations

Tumor-Infiltrating Macrophages Are Associated with Metastasis Suppression in High-Grade Osteosarcoma: A Rationale for Treatment with Macrophage Activating Agents

Emilie P. Buddingh, Marieke L. Kuijjer, R.A.J. Duim et al. · Clinical Cancer Research · 2011 · 501 citations · Full text

SD-101 in Combination with Pembrolizumab in Advanced Melanoma: Results of a Phase Ib, Multicenter Study

Antoni Ribas, Theresa Medina, Shivaani Kummar et al. · Cancer Discovery · 2018 · 328 citations · Full text

Combination immunotherapy with TLR agonists and checkpoint inhibitors suppresses head and neck cancer

Fumi Sato-Kaneko, Shiyin Yao, Alast Ahmadi et al. · JCI Insight · 2017 · 275 citations · Full text

Neck Cancer, Neoadjuvant Therapy, Immunology +26